US Patent 8946392 Gemcitabine immunoassay
Patent 8946392 was granted and assigned to Saladax Biomedical on February, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 14, 2011
Date of Patent
February 3, 2015
Patent Application Number
13160370
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8946392 Gemcitabine immunoassay
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.